Incyte Corp SEC filings INCY

Incyte Corp has 1,002 filings in SEC EDGAR's recent list, going back to Jul 2, 2019. Its latest annual report, Form ARS, was filed on Apr 28, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 29, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 29, 2026 (results of operations). The company's fiscal year ends on December 31.

Form Description Filed Period
S-8 Employee stock plan registration Jul 2, 2025 —
S-8 Employee stock plan registration Jun 18, 2025 —
S-8 Employee stock plan registration Jun 18, 2025 —
S-3ASR Automatic shelf registration Feb 10, 2025 —
S-8 Employee stock plan registration Feb 13, 2024 —
S-8 Employee stock plan registration Jun 30, 2023 —
S-8 Employee stock plan registration Jun 30, 2023 —
S-3ASR Automatic shelf registration Feb 8, 2022 —
S-8 Employee stock plan registration Jun 11, 2021 —
S-8 Employee stock plan registration Jun 15, 2020 —

Showing 10 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Services-Commercial Physical & Biological Research (SIC 8731)
Listed as
INCY (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Wilmington, DE
SEC filer status
Large accelerated filer
SEC CIK
879169
Former names
INCYTE INC (until Mar 28, 2003); INCYTE GENOMICS INC (until Feb 25, 2003); INCYTE PHARMACEUTICALS INC (until Apr 18, 2000)

Other Services-Commercial Physical & Biological Research companies

All 17 Services-Commercial Physical & Biological Research companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.